Abo-abo, Rosalie .
HRN: 26-72-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/18/2025
02/25/2025
IV
1.5g
Q8H
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Central Nervous SystemUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes